<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-147429" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Tetramine Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thompson</surname>
            <given-names>John A.</given-names>
          </name>
          <aff>Oregon Health and Science University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Horowitz</surname>
            <given-names>B. Zane</given-names>
          </name>
          <aff>Oregon Health Science University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Thompson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>B. Zane Horowitz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-147429.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tetramine is an internationally banned rodenticide known for its neurotoxic effects. It is classified as a convulsant that acts on the central nervous system. Notably, tetramine is odorless, colorless, and tasteless, making it difficult to detect. Once ingested, it is rapidly absorbed, and symptoms manifest quickly. Mass exposures are frequent in rural areas where tetramine is commonly used as a rodenticide. Most exposures occur through ingestion. Diagnosing tetramine toxicity requires maintaining a high index of suspicion. Early initiation of treatment and prompt escalation are essential. This activity focuses on the mechanism of action, evaluation, and management of tetramine toxicity. By enhancing recognition and understanding of this condition, healthcare professionals can improve patient care and management of tetramine toxicity.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the signs and symptoms of tetramine toxicity to facilitate prompt recognition and diagnosis.</p></list-item><list-item><p>Implement appropriate management strategies for tetramine toxicity, including supportive care, decontamination measures, and specific antidotes or treatments.</p></list-item><list-item><p>Assess the severity of tetramine toxicity, and monitor vital signs, neurological status, and laboratory parameters to evaluate treatment effectiveness and detect any complications.</p></list-item><list-item><p>Communicate effectively with the healthcare team, patients, and their families to exchange crucial information, provide updates on the patient's condition, and ensure coordinated care.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147429&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147429">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-147429.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Tetramethylenedisulfoteramine (tetramine) is a rodenticide that causes severe neurotoxicity. Though internationally banned, tetramine is still manufactured. There are numerous cases of poisoning, especially in rural areas.&#x000a0;This agent is available through illicit markets in multiple countries and is relatively inexpensive.<xref ref-type="bibr" rid="article-147429.r1">[1]</xref>&#x000a0;</p>
        <p>Due to its chemical stability, ease of production, lack of taste or smell, and rapid onset of toxicity, tetramine has been discussed as a possible candidate for a chemical threat agent.</p>
      </sec>
      <sec id="article-147429.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Tetramine is an inexpensive rodenticide frequently sold&#x000a0;outside the United States, where it is manufactured. Due to the regulations around its manufacture, sale, and ownership, it is sometimes purchased from illegal vendors.</p>
      </sec>
      <sec id="article-147429.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Tetramine synthesis was first documented in Germany in 1949.&#x000a0;The substance's toxicity was discovered through occupational exposure to rayon fabric-impregnated flame retardants. Upholstery workers exposed to the fabric experienced multiple symptoms, including seizures. Further investigation confirmed that the flame retardant agents in the fabric (sulfamide and formaldehyde) reacted and formed tetramine.<xref ref-type="bibr" rid="article-147429.r2">[2]</xref>&#x000a0;Given&#x000a0;the severity of its toxicity and lack of an antidote, it was internationally banned in the 1980s. The manufacture of tetramine is relatively simple, with readily available ingredients. Thus,&#x000a0;illicit production has continued.</p>
        <p>Most documented cases are in China, with more than 14,000 instances reported between 1991 and 2010.<xref ref-type="bibr" rid="article-147429.r3">[3]</xref>&#x000a0;China increased governmental regulations regarding tetramine in 2003, and reported cases declined in the three years following the regulatory change.<xref ref-type="bibr" rid="article-147429.r4">[4]</xref>&#x000a0;However, tetramine sales are still reported in China and other countries.<xref ref-type="bibr" rid="article-147429.r1">[1]</xref>&#x000a0;There has been one reported case in the United States. In 2002, a 15-month-old girl was playing with the powder from an applied rodenticide and began seizing. Despite aggressive therapy, she suffered multiple neurologic sequelae. Testing was performed, confirming the presence of tetramine.<xref ref-type="bibr" rid="article-147429.r5">[5]</xref><xref ref-type="bibr" rid="article-147429.r6">[6]</xref>&#x000a0;</p>
        <p>No intentional poisoning cases have been documented in the United States. A notable case in China occurred when a food vendor poisoned his competitor's food with a tetramine rodenticide. In all, 300 customers were poisoned, and 42 deaths occurred.<xref ref-type="bibr" rid="article-147429.r1">[1]</xref>&#x000a0;Another case of attempted poisoning occurred at a school in Hunan province, where 120 students fell ill when a student tried to poison a teacher, but the tainted ingredients were unknowingly used to serve the school.<xref ref-type="bibr" rid="article-147429.r1">[1]</xref>&#x000a0;</p>
        <p>Due to its use in rural areas as an effective rodenticide, mass exposures are common in the countryside. In 2001, 200 individuals were exposed to tetramine in a&#x000a0;rural area. In addition, due to the stability of tetramine in water for&#x000a0;6 weeks, there have been concerns that poisoned rats eaten by roaming dogs in rural areas may have toxic concentrations in their tissues through bioaccumulation.<xref ref-type="bibr" rid="article-147429.r1">[1]</xref></p>
      </sec>
      <sec id="article-147429.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Tetramine is a noncompetitive GABAa channel antagonist, blocking this inhibitory chloride channel. Early studies noted similarities between tetramine and picrotoxin, another noncompetitive GABAa inhibitor.&#x000a0;The chemical is classified as a cage convulsant based on its structure. The GABAa receptor is a pentameric structure composed of different subunits. Due to the potential variability in subunit composition and genetic variances within subunits, there is a large amount of heterogeneity in the subunit composition of the GABAa receptor in vertebrates.<xref ref-type="bibr" rid="article-147429.r7">[7]</xref>&#x000a0;</p>
        <p>Tetramine has a different affinity for different subunits, and further studies of this have noted that inhibition is incomplete, with a wide range of inhibition (46%-85%) dependent on the subunit makeup of the receptor it is inhibiting.<xref ref-type="bibr" rid="article-147429.r8">[8]</xref>&#x000a0;This range of inhibition, combined with the differences in GABAa subunit composition, speaks to a potential localization of toxicity in discrete areas of the central nervous system and a potential for varying degrees of toxicity based on the receptor structure composition of the poisoned individual.<xref ref-type="bibr" rid="article-147429.r7">[7]</xref>&#x000a0;This incomplete inhibition may also provide insight into the underlying mechanism of action of adjuncts used in poisoned patients.&#x000a0;</p>
        <p>Tetramine also affects calcium dynamics in neurons and the frequency of spontaneous calcium oscillations.<xref ref-type="bibr" rid="article-147429.r9">[9]</xref>&#x000a0;These effects are similarly seen in toxicity caused by picrotoxin, suggesting a similar mechanism of action demonstrated in previous studies.</p>
      </sec>
      <sec id="article-147429.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Tetramine has the chemical formula C4H8NO4S2, and its chemical name is tetramethylenedisulfoteramine. Other names include TMDT, TETS, <italic toggle="yes">Dushuqiang</italic> (very strong rat poison), 4-2-4, and <italic toggle="yes">Sanbudado</italic> (takes&#x000a0;3 steps and keels over).<xref ref-type="bibr" rid="article-147429.r1">[1]</xref><xref ref-type="bibr" rid="article-147429.r3">[3]</xref>&#x000a0;Animal studies report an LD50 as low as 0.1 mg/kg, and human LD50 estimates range from 0.1&#x000a0;to 0.3 mg/kg.<xref ref-type="bibr" rid="article-147429.r2">[2]</xref><xref ref-type="bibr" rid="article-147429.r6">[6]</xref>&#x000a0;</p>
        <p>Tetramine is odorless, colorless, and persistent in the body and the environment.<xref ref-type="bibr" rid="article-147429.r1">[1]</xref>&#x000a0;Tetramine is water soluble.<xref ref-type="bibr" rid="article-147429.r3">[3]</xref><xref ref-type="bibr" rid="article-147429.r5">[5]</xref>&#x000a0;The main route of exposure is through ingestion. There are occupational exposures through inhalation; it is not absorbed through the skin.<xref ref-type="bibr" rid="article-147429.r5">[5]</xref>&#x000a0;Absorption is rapid, with animal studies showing 90% absorption within&#x000a0;1 hour.<xref ref-type="bibr" rid="article-147429.r10">[10]</xref>&#x000a0;</p>
        <p>Thus, symptom onset is rapid, with most cases showing toxicity within 30 minutes of ingestion.<xref ref-type="bibr" rid="article-147429.r5">[5]</xref>&#x000a0;Tetramine excretion is mainly through the urine and is slow. A minor percentage (&#x0003c;20%) is excreted in the bile.<xref ref-type="bibr" rid="article-147429.r10">[10]</xref>&#x000a0;The presence of significant biliary recirculation has not been studied.</p>
      </sec>
      <sec id="article-147429.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>History should attempt to ascertain the amount of tetramine ingested and the time of ingestion. The possibility of co-ingestants should also be shown. The symptomatic onset&#x000a0;is rapid. The physical exam should focus on the neurologic evaluation. Physical exam findings are generally nonspecific. Animal models suggest lethargy and tremor as early toxicity signs.<xref ref-type="bibr" rid="article-147429.r11">[11]</xref>&#x000a0;</p>
        <p>Common symptoms reported from minor toxicity include headache, nausea, vomiting, dizziness, and hallucinations.<xref ref-type="bibr" rid="article-147429.r12">[12]</xref>&#x000a0;Severe cases present with seizures, status epilepticus, multiorgan failure (likely sequelae of intractable seizures), and death.<xref ref-type="bibr" rid="article-147429.r12">[12]</xref>&#x000a0;</p>
        <p>Given the rapid nature of toxicity development, the patient may present in status epilepticus to the hospital setting, and other symptoms might not be prevalent by the time the patient arrives.</p>
      </sec>
      <sec id="article-147429.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis is mainly clinical, and the primary managing team must maintain a high index of suspicion for tetramine toxicity. There are case reports of documented electroencephalography (EEG) changes, including diffuse slow waves, spike-and-slow waves, and sharp and slow waves in children.<xref ref-type="bibr" rid="article-147429.r13">[13]</xref>&#x000a0;Leukocytosis, rhabdomyolysis, and thrombocytopenia&#x000a0;are reported in documented cases.<xref ref-type="bibr" rid="article-147429.r3">[3]</xref>&#x000a0;</p>
        <p>Multiple&#x000a0;studies describe diagnostic testing; however, these tests are not readily available, limiting their benefit in the clinical setting. Gas chromatography with nitrogen phosphorous detection is described as a sensitive technique to detect tetramine.<xref ref-type="bibr" rid="article-147429.r14">[14]</xref>&#x000a0;Other methodologies described include gas chromatography/mass spectroscopy.<xref ref-type="bibr" rid="article-147429.r15">[15]</xref>&#x000a0;</p>
        <p>No pathognomonic findings are reported on CT imaging or MRI for tetramine toxicity.</p>
        <p>Findings on autopsy note lung edema and congestion in all documented cases.<xref ref-type="bibr" rid="article-147429.r3">[3]</xref>&#x000a0;There is bleeding in most organs, with subarachnoid hemorrhage found in 27.5% of cases on autopsy review.<xref ref-type="bibr" rid="article-147429.r3">[3]</xref>&#x000a0;The mechanism for multi-site hemorrhages is unclear and may be related to sequelae of intractable seizures, although this is inconclusive.</p>
      </sec>
      <sec id="article-147429.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Universal precautions are recommended to limit exposure to healthcare providers. As stated earlier, tetramine is unlikely to be absorbed through intact skin.</p>
        <p>Treatment should be started as early as possible as tetramine is rapidly absorbed after oral ingestion, and neurotoxicity occurs suddenly.</p>
        <p>
<bold>Gastric Decontamination</bold>
</p>
        <p>In acute confirmed ingestions, it is reasonable to consider gastric decontamination. The LD50 of tetramine is such that decreasing absorption may mitigate toxicity. However, no robust data or human studies suggest mortality benefits. Regardless, gastric lavage has been reported as a recommended treatment by clinicians with experience treating tetramine poisoning.<xref ref-type="bibr" rid="article-147429.r16">[16]</xref></p>
        <p>An animal study on the effects of activated charcoal use in tetramine-poisoned rabbits demonstrated a decrease in the elimination half-life by 55% and a reduction in the area under the curve by 70%, indicating tetramine is readily bound by activated charcoal.<xref ref-type="bibr" rid="article-147429.r10">[10]</xref>&#x000a0;This data would suggest that activated charcoal may be beneficial in early presentations. However, given the high likelihood of seizures, the risk of aspiration must be considered if the patient's airway is not protected through endotracheal tube placement.</p>
        <p>There are no studies on biliary recirculation, and the benefit of multi-dose activated charcoal is unclear.</p>
        <p>
<bold>Pharmacologic Treatment</bold>
</p>
        <p>A distinctive characteristic of tetramine toxicity is refractory seizures. Multiple classes of drugs have been studied in animals with variable effects. Aggressive and early escalating treatment is recommended regardless of the agents chosen to treat tetramine toxicity. In a case series of&#x000a0;15&#x000a0;patients with tetramine toxicity, the authors advocate for early mechanical ventilation to avoid any hesitancy in escalating treatment with benzodiazepines.<xref ref-type="bibr" rid="article-147429.r16">[16]</xref></p>
        <p>
<bold>Benzodiazepines</bold>
</p>
        <p>Benzodiazepines are one of the more common agents used in&#x000a0;reported cases. Molecular studies demonstrated midazolam&#x000a0;had the best inhibition of tetramine binding to the GABA receptor compared to diazepam and phenobarbitol. However, this has not been studied in humans.<xref ref-type="bibr" rid="article-147429.r17">[17]</xref>&#x000a0;A comparison in an animal poisoning model noted both high-dose diazepam and midazolam improved survival.<xref ref-type="bibr" rid="article-147429.r18">[18]</xref> Animal&#x000a0;studies reported improvement in seizure resolution with diazepam but no change in death rate at&#x000a0;60&#x000a0;minutes.<xref ref-type="bibr" rid="article-147429.r19">[19]</xref>&#x000a0;</p>
        <p>
<bold>Sedative Hypnotics</bold>
</p>
        <p>Early animal studies suggest aggressive sedative therapy with an agent such as phenobarbital is beneficial.<xref ref-type="bibr" rid="article-147429.r20">[20]</xref>&#x000a0;</p>
        <p>Molecular studies suggested propofol appears to have similar efficacy as midazolam in blocking tetramine binding to the GABA receptor.<xref ref-type="bibr" rid="article-147429.r17">[17]</xref></p>
        <p>
<bold>NMDA Receptor Inhibitors</bold>
</p>
        <p>Ketamine was studied in mice, and with higher doses (70 mg/kg intraperitoneal), convulsions decreased, and the 60-minute death rate was decreased.<xref ref-type="bibr" rid="article-147429.r19">[19]</xref></p>
        <p>
<bold>Adjuncts</bold>
</p>
        <p>Where tetramine cases are more commonly seen, treatment adjuncts are used frequently. Randomized controlled trials in humans for these adjuncts are lacking, and reports of the effects are limited to animal studies and case reports/series.</p>
        <p>
<bold>Pyridoxine</bold>
</p>
        <p>Vitamin B6 has been reported as a helpful adjunct in cases of tetramine toxicity. Data is limited on efficacy, and the exact mechanism is unclear. As previously mentioned, tetramine is a noncompetitive inhibitor of the GABAa receptor. Pyridoxine is used in other poisons that cause neurotoxicity, such as gyromitra and isoniazid toxicity. These agents contribute to seizures by depleting the active form of pyridoxine, pyridoxal 5-phosphate, an essential cofactor in GABA formation. Animal studies have demonstrated that pyridoxine combined with sodium 2,3-dimercaptopropanesulfonate (DMPS) decreased convulsions.<xref ref-type="bibr" rid="article-147429.r21">[21]</xref></p>
        <p>
<bold>Sodium 2,3-dimercaptopropanesulfonate (DMPS)</bold>
</p>
        <p>DMPS, a chelating agent for heavy metals, has been suggested as a treatment modality for tetramine-poisoned patients. In addition to being used as a combination treatment with pyridoxine, animal studies demonstrated the potential benefit of DMPS alone. Proposed mechanisms involve the sulfhydryl groups and their ability to modulate the function of various ion channels. Rat studies showed decreased convulsions with DMPS alone due to the potentiation of GABA at the receptor site.<xref ref-type="bibr" rid="article-147429.r22">[22]</xref></p>
        <p>
<bold>Medication Adjuncts Under Investigation</bold>
</p>
        <p>
<bold>Neurosteroids</bold>
</p>
        <p>Neurosteroids are another class of drugs undergoing research as a treatment for tetramine toxicity. Neurosteroids interact with GABAa receptors both in the synaptic cleft and at extrasynaptic GABAa receptors, the latter of which&#x000a0;are not sensitive to benzodiazepines.<xref ref-type="bibr" rid="article-147429.r23">[23]</xref>&#x000a0;Activation of these extrasynaptic receptors leads to tonic inhibition instead of phasic inhibition at the synaptic cleft.<xref ref-type="bibr" rid="article-147429.r7">[7]</xref>&#x000a0;Neurosteroids are positive allosteric modulators and can increase benzodiazepine affinity to the GABAa receptor when bound at the same complex.<xref ref-type="bibr" rid="article-147429.r24">[24]</xref>&#x000a0;</p>
        <p>In addition to the modulating effects of neurosteroids, there appears to be a synergistic effect of benzodiazepines and neurosteroids. Combination therapy of diazepam and allopregnanolone (a neurosteroid used to treat postpartum depression) demonstrated normalization of tetramine-induced synchronous calcium oscillations in rodents and improved survival from&#x000a0;ten percent to 90%.<xref ref-type="bibr" rid="article-147429.r25">[25]</xref></p>
        <p>
<bold>Extracorporeal&#x000a0;Removal</bold>
</p>
        <p>Extracorporeal removal of tetramine has been implemented in many instances of poisoning through various modalities, including plasma exchange, hemodialysis (HD), high volume hemofiltration (HVHF), continuous venovenous hemofiltration (CVVH), and charcoal hemoperfusion. There have not been large comparison studies in humans. Expert opinion on this as a treatment is mixed, and recommendations vary.<xref ref-type="bibr" rid="article-147429.r26">[26]</xref><xref ref-type="bibr" rid="article-147429.r15">[15]</xref><xref ref-type="bibr" rid="article-147429.r27">[27]</xref>&#x000a0;If extracorporeal is used as treatment, early initiation may result in decreased time to recovery based on a case series.<xref ref-type="bibr" rid="article-147429.r28">[28]</xref></p>
        <p>Charcoal hemoperfusion appears to be the more common modality, as studies have demonstrated that this method does remove tetramine from the body quickly. A two-hour session removed 1 mg of tetramine (measured from the perfusion device) when the initial plasma concentration was 100 mcg/L.<xref ref-type="bibr" rid="article-147429.r26">[26]</xref>&#x000a0;That result is compared to urinary excretion of 80&#x000a0;mcg at 48 hours recorded in the same study. Lab analysis also showed decreased efficacy during longer sessions, suggesting that the perfusion filter was saturated with tetramine and became ineffective.<xref ref-type="bibr" rid="article-147429.r26">[26]</xref>&#x000a0;A logistical issue is charcoal hemoperfusion is not reliably available, even in large metropolitan hospitals, which may affect treatment strategy.<xref ref-type="bibr" rid="article-147429.r29">[29]</xref>&#x000a0;</p>
        <p>There are conflicting reports concerning extracorporeal removal. Some studies document pre-filtration and post-filtration concentrations in patients and note no significant change in concentration, bringing into question the efficacy of extracorporeal removal.<xref ref-type="bibr" rid="article-147429.r26">[26]</xref>&#x000a0;Other case series also note this phenomenon with a recurrence of seizures in the days following hemoperfusion.<xref ref-type="bibr" rid="article-147429.r13">[13]</xref>&#x000a0;However, different case series document improvement in tetramine concentrations after hemoperfusion, suggesting that the conflicting results are more likely related to the differences in tetramine amount ingested for each individual in the reported cases.<xref ref-type="bibr" rid="article-147429.r30">[30]</xref>&#x000a0;</p>
        <p>Given the distribution of tetramine throughout the body, this observation is thought to be more likely due to the redistribution of tetramine from body tissues into the serum, as studies have documented that tetramine is removed by charcoal hemoperfusion by directly analyzing the filter contents.<xref ref-type="bibr" rid="article-147429.r26">[26]</xref><xref ref-type="bibr" rid="article-147429.r15">[15]</xref>&#x000a0;</p>
        <p>A case of a patient that received high-volume hemofiltration seven days after poisoning noted a decrease in tetramine concentration from 0.95 mcg/mL to 0.35 mcg/mL. The following day the serum concentration rebounded to 0.53 mcg/mL, and charcoal hemoperfusion was performed, lowering the concentration to 0.40 mcg/mL.<xref ref-type="bibr" rid="article-147429.r12">[12]</xref>&#x000a0;</p>
        <p>Serum rebound is frequently reported in published cases. Thus, additional sessions may be indicated.&#x000a0;Eighteen patients received hemoperfusion followed by CVVH, which was more effective at removing tetramine.<xref ref-type="bibr" rid="article-147429.r28">[28]</xref>&#x000a0;This may mitigate rebound after hemoperfusion, though more study is needed.&#x000a0;</p>
        <p>
<bold>Extracorporeal Removal on Long-term Outcomes</bold>
</p>
        <p>A case series of 17 children with an unintentional ingestion of tetramine compared outcome differences in those that received charcoal hemoperfusion and those that did not; the non-hemoperfusion group had a higher incidence of seizures.<xref ref-type="bibr" rid="article-147429.r13">[13]</xref>&#x000a0;</p>
        <p>EEG abnormalities were monitored at regular intervals, and the hemoperfusion group had a resolution of EEG abnormalities at six months, whereas the non-hemoperfusion group took a year to recover. This same study noted a quicker time to recovery in individuals that received multiple&#x000a0;occurrences of hemoperfusion.<xref ref-type="bibr" rid="article-147429.r13">[13]</xref>&#x000a0;This is&#x000a0;reported&#x000a0;in the literature, as stated previously.</p>
      </sec>
      <sec id="article-147429.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Sodium monofluoroacetate toxicity</p>
          </list-item>
          <list-item>
            <p>Stimulant abuse</p>
          </list-item>
          <list-item>
            <p>Isoniazid toxicity</p>
          </list-item>
          <list-item>
            <p>Organophosphate compound toxicity</p>
          </list-item>
          <list-item>
            <p>Serotonin toxicity</p>
          </list-item>
          <list-item>
            <p>Hydrazine toxicity</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Severe electrolyte derangements</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-147429.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Left untreated, severe tetramine toxicity is invariably fatal.&#x000a0;With rapid and aggressive escalating treatment, mortality is notably diminished. In an observational study of confirmed cases in China from 2000 to 2012, there were 3526 cases and 225 deaths (6%).<xref ref-type="bibr" rid="article-147429.r4">[4]</xref></p>
      </sec>
      <sec id="article-147429.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications surrounding tetramine toxicity are neurological in nature. Pediatric studies have documented prolonged EEG changes after treatment.<xref ref-type="bibr" rid="article-147429.r13">[13]</xref>&#x000a0;</p>
        <p>Seizures are a common complication after the acute toxicity phase.&#x000a0;A follow-up study of 370 previously healthy poisoning survivors noted that 55% had seizures at follow-up.&#x000a0;Of those who were seizure-free at the follow-up, most&#x000a0;had been placed on antiepileptic medication initially and were seizure-free off the drug by an average of 2.3 years. Of the remaining 195 patients with seizures, most experienced tonic-clonic seizures, while the minority (39) had partial seizures.<xref ref-type="bibr" rid="article-147429.r31">[31]</xref>&#x000a0;Of those surveyed, a minority had other neurologic sequelae, such as gait instability, cognitive deficits, and intractable epilepsy.<xref ref-type="bibr" rid="article-147429.r31">[31]</xref>&#x000a0;These long-term sequelae are also reported in case literature.<xref ref-type="bibr" rid="article-147429.r6">[6]</xref></p>
        <p>It should be noted that a small number of patients with minor toxicity experience long-term complications of seizures without having seizures at the initial presentation. At follow-up in the previous observational study, all of these patients continued to have seizures.</p>
      </sec>
      <sec id="article-147429.s13" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>After discharge from the hospital, patients will likely need close neurology follow-up and monitoring as they may continue to have seizures. Sodium valproate has been used in these patients. However, there has been no comparison study on antiepileptics to control the sequela of seizures in tetramine-poisoned patients.<xref ref-type="bibr" rid="article-147429.r6">[6]</xref><xref ref-type="bibr" rid="article-147429.r31">[31]</xref></p>
      </sec>
      <sec id="article-147429.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultation with a medical toxicologist or the regional poison center is often necessary.</p>
      </sec>
      <sec id="article-147429.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Preventative education is critical to minimizing tetramine poisoning. This toxin's effectiveness, low cost, and stability make it&#x000a0;an appealing rodenticide. However, safer, legal alternatives should be used.</p>
      </sec>
      <sec id="article-147429.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional healthcare team, consisting of emergency department clinicians, toxicology specialists, and intensive care professionals, is crucial for the optimal management of tetramine poisoning. Early and aggressive treatment of seizures and appropriate sedation should be implemented. The long-term sequelae and multi-organ effects of tetramine poisoning are believed to be primarily associated with refractory seizures. While there have been case reports and promising results in animal models regarding the use of adjunct medications and elimination techniques, the lack of human data prevents routine recommendation of these interventions. Consulting a toxicologist or regional poison center is advised to consider these treatments.</p>
      </sec>
      <sec id="article-147429.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147429&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147429">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/poisons/tetramine-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=147429">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/147429/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=147429">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-147429.s18">
        <title>References</title>
        <ref id="article-147429.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Croddy</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Rat poison and food security in the People's Republic of China: focus on tetramethylene disulfotetramine (tetramine).</article-title>
            <source>Arch Toxicol</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>78</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">14551672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shakarjian</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Laukova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vel&#x000ed;&#x00161;kov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stanton</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Heck</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Vel&#x000ed;&#x00161;ek</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Tetramethylenedisulfotetramine: pest control gone awry.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>1378</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-79</page-range>
            <pub-id pub-id-type="pmid">27384716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Tetramine poisoning: A case report and review of the literature.</article-title>
            <source>Forensic Sci Int</source>
            <year>2011</year>
            <month>Jan</month>
            <day>30</day>
            <volume>204</volume>
            <issue>1-3</issue>
            <fpage>e24</fpage>
            <page-range>e24-7</page-range>
            <pub-id pub-id-type="pmid">20678875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Tetramine poisoning in China: changes over a decade viewed through the media's eye.</article-title>
            <source>BMC Public Health</source>
            <year>2014</year>
            <month>Aug</month>
            <day>13</day>
            <volume>14</volume>
            <fpage>842</fpage>
            <pub-id pub-id-type="pmid">25115223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrueto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Furdyna</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Status epilepticus from an illegally imported Chinese rodenticide: "tetramine".</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>2003</year>
            <volume>41</volume>
            <issue>7</issue>
            <fpage>991</fpage>
            <page-range>991-4</page-range>
            <pub-id pub-id-type="pmid">14705847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Poisoning by an illegally imported Chinese rodenticide containing tetramethylenedisulfotetramine--New York City, 2002.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2003</year>
            <month>Mar</month>
            <day>14</day>
            <volume>52</volume>
            <issue>10</issue>
            <fpage>199</fpage>
            <page-range>199-201</page-range>
            <pub-id pub-id-type="pmid">12653458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laukov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vel&#x000ed;&#x00161;kov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vel&#x000ed;&#x00161;ek</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shakarjian</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Tetramethylenedisulfotetramine neurotoxicity: What have we learned in the past 70&#x0202f;years?</article-title>
            <source>Neurobiol Dis</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>133</volume>
            <fpage>104491</fpage>
            <pub-id pub-id-type="pmid">31176716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pressly</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Wulff</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>GABA<sub>A</sub> receptor subtype selectivity of the proconvulsant rodenticide TETS.</article-title>
            <source>Arch Toxicol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>833</fpage>
            <page-range>833-844</page-range>
            <pub-id pub-id-type="pmid">29038840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Hammock</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rogawski</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lein</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Pessah</surname>
                <given-names>IN</given-names>
              </name>
            </person-group>
            <article-title>Tetramethylenedisulfotetramine alters Ca&#x000b2;&#x0207a; dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation.</article-title>
            <source>Toxicol Sci</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>362</fpage>
            <page-range>362-72</page-range>
            <pub-id pub-id-type="pmid">22889812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>[Toxicokinetics of tetramethylene disulphotetramine].</article-title>
            <source>Zhonghua Yu Fang Yi Xue Za Zhi</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>91</fpage>
            <page-range>91-4</page-range>
            <pub-id pub-id-type="pmid">15842825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rice</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Rauscher</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Langston</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Behavioral intoxication following voluntary oral ingestion of tetramethylenedisulfotetramine: Dose-dependent onset, severity, survival, and recovery.</article-title>
            <source>Neurotoxicology</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>63</volume>
            <fpage>21</fpage>
            <page-range>21-32</page-range>
            <pub-id pub-id-type="pmid">28855111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chau</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>IK</given-names>
              </name>
            </person-group>
            <article-title>Tetramine poisoning.</article-title>
            <source>Hong Kong Med J</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>511</fpage>
            <page-range>511-4</page-range>
            <pub-id pub-id-type="pmid">16340030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cui</surname>
                <given-names>FX</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>[Effect of hemoperfusion on prognosis in dushuqiang (tetramine) poisoning].</article-title>
            <source>Zhonghua Er Ke Za Zhi</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>12</issue>
            <fpage>950</fpage>
            <page-range>950-1</page-range>
            <pub-id pub-id-type="pmid">14723826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jing</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>HZ</given-names>
              </name>
            </person-group>
            <article-title>Determination of tetramine in postmortem specimens by GC-NPD.</article-title>
            <source>J Anal Toxicol</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>275</fpage>
            <page-range>275-7</page-range>
            <pub-id pub-id-type="pmid">7990447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guan</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>QY</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>ZW</given-names>
              </name>
            </person-group>
            <article-title>GC/MS identification of tetramine in samples from human alimentary intoxication and evaluation of artificial carbonic kidneys for the treatment of the victims.</article-title>
            <source>J Anal Toxicol</source>
            <year>1993</year>
            <season>Jul-Aug</season>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>199</fpage>
            <page-range>199-201</page-range>
            <pub-id pub-id-type="pmid">8371547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>[Clinical analysis of 15 cases with tetramethylenedisulfotetramine].</article-title>
            <source>Hunan Yi Ke Da Xue Xue Bao</source>
            <year>2001</year>
            <month>Feb</month>
            <day>28</day>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-6</page-range>
            <pub-id pub-id-type="pmid">12536621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Buchholz</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Lightstone</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hammock</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Casida</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>GABAA receptor target of tetramethylenedisulfotetramine.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2014</year>
            <month>Jun</month>
            <day>10</day>
            <volume>111</volume>
            <issue>23</issue>
            <fpage>8607</fpage>
            <page-range>8607-12</page-range>
            <pub-id pub-id-type="pmid">24912155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moffett</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rauscher</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Survey of drug therapies against acute oral tetramethylenedisulfotetramine poisoning in a rat voluntary consumption model.</article-title>
            <source>Neurotoxicology</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>74</volume>
            <fpage>264</fpage>
            <page-range>264-271</page-range>
            <pub-id pub-id-type="pmid">31408636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shakarjian</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Vel&#x000ed;&#x00161;kov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stanton</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Vel&#x000ed;&#x00161;ek</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABA(A) receptors.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <year>2012</year>
            <month>Nov</month>
            <day>15</day>
            <volume>265</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-21</page-range>
            <pub-id pub-id-type="pmid">23022509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>VOSS</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>HASKELL</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>GARTENBERG</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Reduction of tetramine toxicity by sedatives and anticonvulsants.</article-title>
            <source>J Pharm Sci</source>
            <year>1961</year>
            <month>Oct</month>
            <volume>50</volume>
            <fpage>858</fpage>
            <page-range>858-60</page-range>
            <pub-id pub-id-type="pmid">13926817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qiu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Antidotal effects of vitamin B(6) and sodium dimercaptopropane sulfonate on acute poisoning with tetramethylene disulphotetramine in animals].</article-title>
            <source>Zhonghua Nei Ke Za Zhi</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>186</fpage>
            <page-range>186-8</page-range>
            <pub-id pub-id-type="pmid">11940321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>GX</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>DX</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>ZK</given-names>
              </name>
            </person-group>
            <article-title>Effect of sodium dimercaptopropanesulfonate on antagonism of tetramethylenedisulphotetramine to GABA receptor.</article-title>
            <source>Acta Pharmacol Sin</source>
            <year>2001</year>
            <month>May</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>435</fpage>
            <page-range>435-9</page-range>
            <pub-id pub-id-type="pmid">11743892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brickley</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Mody</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.</article-title>
            <source>Neuron</source>
            <year>2012</year>
            <month>Jan</month>
            <day>12</day>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-34</page-range>
            <pub-id pub-id-type="pmid">22243744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hawkinson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kimbrough</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Belelli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Purdy</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.</article-title>
            <source>Mol Pharmacol</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>977</fpage>
            <page-range>977-85</page-range>
            <pub-id pub-id-type="pmid">7969089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruun</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Inceoglu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vito</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Hulsizer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hammock</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Tancredi</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rogawski</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Pessah</surname>
                <given-names>IN</given-names>
              </name>
              <name>
                <surname>Lein</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures.</article-title>
            <source>Neuropharmacology</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>95</volume>
            <fpage>332</fpage>
            <page-range>332-42</page-range>
            <pub-id pub-id-type="pmid">25882826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ge</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Guan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Study on the effect using hemoperfusion to treat tetramine poisoned patients].</article-title>
            <source>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>403</fpage>
            <page-range>403-4</page-range>
            <pub-id pub-id-type="pmid">14694583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whitlow</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Belson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barrueto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Tetramethylenedisulfotetramine: old agent and new terror.</article-title>
            <source>Ann Emerg Med</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>609</fpage>
            <page-range>609-13</page-range>
            <pub-id pub-id-type="pmid">15940093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dehua</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Daxi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Honglang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bin</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yun</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Leishi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Sequential hemoperfusion and continuous venovenous hemofiltration in treatment of severe tetramine poisoning.</article-title>
            <source>Blood Purif</source>
            <year>2006</year>
            <volume>24</volume>
            <issue>5-6</issue>
            <fpage>524</fpage>
            <page-range>524-30</page-range>
            <pub-id pub-id-type="pmid">17077625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shalkham</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Kirrane</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>The availability and use of charcoal hemoperfusion in the treatment of poisoned patients.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>239</fpage>
            <page-range>239-41</page-range>
            <pub-id pub-id-type="pmid">16860189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>MX</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>HX</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>[Application of hemoperfusion in children with acute tetramine poisoning].</article-title>
            <source>Zhongguo Dang Dai Er Ke Za Zhi</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>536</fpage>
            <page-range>536-8</page-range>
            <pub-id pub-id-type="pmid">20637151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147429.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mei</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Long term effects of tetramine poisoning: an observational study.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>50</volume>
            <issue>3</issue>
            <fpage>172</fpage>
            <page-range>172-5</page-range>
            <pub-id pub-id-type="pmid">22315994</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
